Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 2010

View Archived Issues

Correlation between genetic variations in Lp(a) lipoprotein and risk of CAD identified

Crystal structure of PI3Kdelta in complex with inhibitors allows design of enhanced agents

Novo Nordisk: 2009 in review

Rexahn provides update on goals for 2010

Nippon Shinyaku and Actelion enter into license agreement on novel PAH therapeutic

Biodegradable nanocarriers with drug delivery and imaging properties described as theranostic agents

Otonomy receives FDA clearance for trial in Meniere's disease

Pulmonary blood density measured by MRI may be used in PAH and heart failure prognosis

Javelin receives FDA PDUFA date for Dyloject NDA for pain

Ligand reports discovery of dual AT1/ETA receptor antagonists

Roche presents novel CCR2 antagonists

Cardiac reserve index differentiates heart failure patients from healthy subjects

Marcadia Biotech initiates phase I trial of MAR-701

Genfit reports the identification of novel PPAR agonists

Georgetown University discloses MLCP inhibitors for cancer therapy

Merck KGaA discloses novel SphK1 and Met kinase inhibitors

MorphoSys and Galapagos add another antibody target to alliance in bone and joint diseases

TD2 and Rondaxe sign alliance to help emerging companies develop cancer therapeutics

BioMimetic completes submission of PMA to FDA for Augment Bone Graft

Biogen and Biovitrum restructure collaboration agreement for rFVIIIFc and rFIXFc

Michael J. Fox Foundation funds research into LRRK2 gene

Hollis-Eden Pharmaceuticals becomes Harbor BioSciences

FDA issues complete response letter for GSK's Horizant in RLS

Pharmasset updates progress of RG-7128 studies

Pivotal Research adds U.S. center to phase II study of VA-111913 for dysmenorrhea

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...